139 related articles for article (PubMed ID: 36917018)
1. The Impact of SARS-COV-2 on two Colorectal Cancer screening centres.
Ring É; Conlon C; Kerr H; Cudmore J; King S; O'Grady J; Devlin S; Fitzpatrick P; Leyden J; Cullen G; MacMathúna P; Doherty G; Lahiff C
Ir Med J; 2023 Jan; 116(No.1):3. PubMed ID: 36917018
[TBL] [Abstract][Full Text] [Related]
2. The impact of delaying colonoscopies during the COVID-19 pandemic on colorectal cancer detection and prevention.
Holland J; Cwintal M; Rigas G; Pang AJ; Vasilevsky CA; Morin N; Ghitulescu G; Faria J; Boutros M
Surg Endosc; 2022 Dec; 36(12):9364-9373. PubMed ID: 35428894
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
4. The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex.
Vojtechova G; Ngo O; Grega T; Kmochova K; Voska M; Buckova B; Majek O; Zavoral M; Suchanek S
Eur J Cancer Prev; 2020 Jul; 29(4):294-302. PubMed ID: 32543806
[TBL] [Abstract][Full Text] [Related]
5. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.
Wassie MM; Young GP; Cock C; Bampton P; Winter JM; Simpson K; Saluja H; Chuang A; Fraser RJ; Symonds EL
J Gastroenterol Hepatol; 2022 Jun; 37(6):1067-1075. PubMed ID: 35261071
[TBL] [Abstract][Full Text] [Related]
7. Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.
Choy AM; Lebwohl B; Krigel A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):739-743. PubMed ID: 35102113
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program.
D'Ovidio V; Lucidi C; Bruno G; Lisi D; Miglioresi L; Bazuro ME
Clin Colorectal Cancer; 2021 Mar; 20(1):e5-e11. PubMed ID: 32868231
[TBL] [Abstract][Full Text] [Related]
9. Neoplasia at 10-year follow-up screening colonoscopy in a private U.S. practice: comparison of yield to first-time examinations.
Rex DK; Ponugoti PL; Johnson CS; Kittner L; Yanda RJ
Gastrointest Endosc; 2018 Jan; 87(1):254-259. PubMed ID: 28478026
[TBL] [Abstract][Full Text] [Related]
10. Patient Decisions Regarding Rescheduling Colonoscopies Postponed Due to the COVID-19 Pandemic.
Linz MO; Lorincz-Comi N; Kuwatch AA; Cooper GS
Dig Dis Sci; 2023 Dec; 68(12):4339-4349. PubMed ID: 37794293
[TBL] [Abstract][Full Text] [Related]
11. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.
Delavari A; Bishehsari F; Salimzadeh H; Khosravi P; Delavari F; Nasseri-Moghaddam S; Merat S; Ansari R; Vahedi H; Shahbazkhani B; Saberifiroozi M; Sotoudeh M; Malekzadeh R
BMC Gastroenterol; 2014 Nov; 14():196. PubMed ID: 25404264
[TBL] [Abstract][Full Text] [Related]
12. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
[TBL] [Abstract][Full Text] [Related]
13. High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.
Walshe M; Moran R; Boyle M; Cretu I; Galvin Z; Swan V; Trikovic J; Farrell MP; Foy S; O'Brien L; Leyden J; Mulligan N; Fenlon H; Gallagher DJ; MacMathúna P
Cancer Epidemiol; 2017 Oct; 50(Pt A):30-38. PubMed ID: 28783501
[TBL] [Abstract][Full Text] [Related]
14. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.
Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707
[TBL] [Abstract][Full Text] [Related]
15. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
[TBL] [Abstract][Full Text] [Related]
16. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
[TBL] [Abstract][Full Text] [Related]
17. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
[TBL] [Abstract][Full Text] [Related]
18. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.
Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R
Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824
[TBL] [Abstract][Full Text] [Related]
19. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.
Kortlever TL; de Jonge L; Wisse PHA; Seriese I; Otto-Terlouw P; van Leerdam ME; Spaander MCW; Dekker E; Lansdorp-Vogelaar I
Prev Med; 2021 Oct; 151():106643. PubMed ID: 34217421
[TBL] [Abstract][Full Text] [Related]
20. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
